Fidia In
Wound CARE
WE ARE FIDIA
We are an Italian multinational, established in 1946, with a vocation to create solutions to meet new challenges in health and improve people’s true quality of life.
We have understood the regenerating potential of hyaluronic acid since the 1950s and today we are one of the leading global players in the manufacture of hyaluronic acid-based products. Full control of the supply chain, from research to marketing, sets us apart and for this reason we define ourselves as a fully integrated company.
OUR COMMITMENT IN wound CARE
Since 1963, building on hyaluronic acid and leveraging synergies with regenerative medicine, Fidia Farmaceutici has been at the forefront of developing innovative solutions that enable physicians to provide customized, science-based treatments for patients with acute and chronic wounds.
Our commitment to quality ensures that our products are safe, effective, and reliable, meeting the highest standards of regulatory compliance.
At Fidia Farmaceutici, we believe in empowering patients and healthcare professionals with knowledge and resources to promote proactive skin care. Through continuous research and development, we aim to improve patient outcomes and enhance the quality of life for those living with acute and chronic wounds.
OUR INNOVATION
HYALURONIC ACID iN WOUND CARE
More than 60 years of research into hyaluronic acid molecule have placed Fidia Farmaceutici at the forefront in the production of both natural and functionalized hyaluronic acid, using proprietary and validated manufacturing processes, with different ranges of molecular weight, according to the design characteristics of the finished products.
Today, building on its extensive experience in the clinical applications of hyaluronic acid and tissue regeneration, Fidia Farmaceutici offers innovative treatments, enabling physicians to tailor the best therapy for each patient.
REGENERATIVE CARE IN WOUND CARE
Committed to advancing regenerative medicine, we provide solutions that enable physicians to deliver personalized, science-based therapies using autologous skin fragments directly at the site of treatment, ensuring safety, quality, and effectiveness.
Advance Wound Solutions
Over the past several decades, T.I.M.E. has been adopted as the International Guideline for ulcer treatment. The need to challenge and innovate encouraged Fidia Farmaceutici to move forward to the REGENERATIVE ASPECT OF WOUND HEALING and propose a novel hyaluronic acid-based bioactive line, thereby adding a final R to T.I.M.E., to address the tissue repair/regeneration.
